Reading our Science Market Update blog is a great way to stay informed of industry trends and research, funding and life science building news, but did you know that there is also a great deal of funding and life science market news available on our company news blog? We have put together a list, including links to the articles, of some recent news posted on our Life Science Company and Industry News Briefs blog available to life science sales and marketing professionals interested in staying informed of life science marketing and industry news.
Science Market Update
Tags: Rockefeller University, California, New York, Southwest, Alabama, Arizona, University of Arizona, industry news, Pennsylvania, University of Pennsylvania, University of Pittsburgh, University of California Los Angeles, Massachusetts, Harvard, Northeast, Boston, Philadelphia, Birmingham, Pittsburgh, University of Alabama, Los Angeles, BioResearch Product Faire Event, UPenn, UPITT, Harvard University, Stony Brook, funding news, Tucson, 2014, Science Market Update, Life Science Company and Industry News Briefs, Science Researcher Update, NIH grants, life science events, Southern, LAVS, UAZ, SunySB, RockU, UAlab, Front Line
Researchers at the University of Pittsburgh have developed a way to mimic the biological responses of animals such as octopi or cuttlefish, which change their shape in the face of danger, by eliciting a biomimetic response using hydrogels. Hydrogels are used in most contact lenses and microfluidic or fluid-controlled technologies already, but the University of Pittsburgh researchers were able to redesign them to be reconfigured and controlled by light in a self-sustained movement. The study was recently published in the journal Advanced Functional Materials.
Science researchers at the University of Pittsburgh recently published a study that found that patients suffering from SAD – Seasonal Affective Disorder – had misconceptions about sleep similar to those of insomniacs that prevent them from sleeping soundly at night. According to a University of Pittsburgh news article, the paper was titled “The Role of Beliefs and Attitudes About Sleep in Seasonal and Nonseasonal Mood Disorder, and Nondepressed Controls” and was published in the Journal of Affective Disorders this May.
Lab scientists at the University of Pittsburgh Cancer Institute and UP's Center for Biologic Imaging have recently published an important paper in the Journal of Cell Science that sheds light on a novel method of interrupting mitosis in a cell by effectively depriving its mitochondria of a key protein. The resulting replication stress means cancer cells are stopped from successfully multiplying. Colorful images of the targeted cells actually show them stuck in anaphase trying to divide and subsequently tearing themselves apart. By identifying a compound that carries out this protein interference and disrupts normal mitochondrial fission, researchers have identified a promising therapeutic avenue for halting cancer growth.
Tags: cancer research, NIH, cell biology, Pennsylvania, University of Pittsburgh, Microscopy, Northeast, Pittsburgh, Cell Research, Northeast Region, BioResearch Product Faire Event, PA, UPITT, Hillman Cancer Center, 2013, 2014
In order for HIV to proliferate and infect new cells in the body, a number of proteins need to interact with each other in just the right way. If they don't, the virus is not able to multiply and spread, and HIV infection cannot develop into full-blown Auto Immune Deficiency Syndrome (AIDS). It's a case of finding a weak link and exploiting its potential to disrupt an entire supply chain. In the University of Pittsburgh microbiology lab of Dr. Thomas Smithgall, this protein sabotage approach has successfully allowed them to identify a helper molecule that, if compromised, could form the basis of an effective new HIV/AIDS treatment therapy. The paper documenting their research appeared in the January 24 issue of Chemistry & Biology.
You've heard the phrase "a force of nature," but we'd have to say that the University of Pittsburgh is clearly a force of science based on several recent news items: the University ranks in the Top 3 among public institutions of higher learning in the US (according to the NSF); they're in the Top 5 in federally financed research and development expenditures; and they've just had 3 of their faculty scientists elected to the prestigious National Academy of Sciences. Chancellor Mark Nordenberg says of the first honor:
The 225th Anniversary of the University of Pittsburgh will be celebrated this year. One of their most notable accomplishments was contributing to the launch of the "Biotech Industry". Herbert Boyer, a Pitt PhD graduate helped discover how to cut and transfer individual genes within the DNA molecule and transfer them from one organism to another. Boyer eventually founded Genetech, widely considered one of the first successful biotech companies.
With many accomplishments, in 2000, Herbert Boyer and his wife established the Herbert W. and Grace Boyer Chair in molecular biology in the University of Pittsburgh’s Department of Biological Sciences. Today the Herbert W. and Grace Boyer Chair in Molecular Biology is used to support an outstanding faculty member in the field of post-genomic molecular biology.
Tags: University of Pittsburgh, Northeast, Life Science Funding, UPITT, 2012, BioResearch Product Faire Event, Research Funding, Life Science Marketing, Biotechnology, laboratory product show, current science events, PA, bioscience event, Pittsburgh, Laboratory Equipment Supplier, BRPF, scientific sales, Science sales, scientific supplies, scientific equipment
The University of Pittsburgh Medical Center (UPMC) recently released a quarterly financial report that showed solid growth for Western Pennsylvania's largest health care provider and one of the largest nonprofit health systems in the US. It also announced that it will be begin construction on a $300M facility to house its nascent Center for Innovative Science, which "will bring together leading scientists willing to develop bold, new approaches to understanding complex diseases," according to UPMC's president. In conjunction with its academic partner, the University of Pittsburgh, UPMC is already recruiting nationally for "a scientific leader in genetics and genomics" to head the center.
Dr. Robert Kormos at the University of Pittsburgh's McGowan Institute for Regenerative Medicine has secured $13.3 million in funding from the NIH's Heart, Lung and Blood Institute (NHLBI) to carry out a 5-year heart device study in collaboration with researchers at the University of Michigan. Both the University of Pittsburgh Medical Center and Michigan's Center for Circulatory Support are leaders in research on and implantation of artificial hearts (also known as mechanical circulatory support devices).